GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Top 10 Sequencing Companies
2018年4月9日 · Macrogen. 2017 revenues: KRW 101.8 billion ($95.4 million) Macrogen celebrated its 20 th anniversary last year as a provider of sequencing services. It is South Korea’s largest sequencing ...
Top 10 Contract Development and Manufacturing Organizations
2023年9月15日 · 10. MilliporeSigma. • Announced a $25 million expansion of its Lenexa, KS, facility that will add 98,000 square feet of laboratory and production space for manufacturing cell culture media ...
Top 25 Biotech Companies of 2024 - genengnews.com
2024年1月12日 · Just missing the list at number 26 is BioMarin Pharmaceutical, which had a market cap of $17.51 billion on December 8, followed by WuXi Biologics ($15.94 billion), UCB ($15.52 billion), Novozymes ...
News - GEN - Genetic Engineering and Biotechnology News
GEN – Genetic Engineering and Biotechnology News. GEN Edge. Featured News; Multimedia; News. Insights; Topics. Artificial Intelligence
Making History with the 1990 Gene Therapy Trial
2016年3月10日 · At the age of four years, DeSilva made history at 12:52 p.m. on September 14, 1990, as the first patient to undergo an approved application of gene therapy. She was part of a trial authorized by ...
Top 10 RNA-Based Biopharmas - genengnews.com
2021年11月17日 · In GEN’s initial A-List published in 2018, the top five public companies generated a combined $1.536 billion in revenues for 2017 and the first three quarters of 2018.By contrast, the top five ...
Top 10 Biomedical Issues of the Next Decade - genengnews.com
2020年2月1日 · Gene therapies are still in use, but genetic medicine and counseling are shifting toward prevention. Some governments are taking an interest in encouraging gene editing to control the high cost of ...
Top 10 Biopharma Takeover Targets of 2024 - genengnews.com
2024年2月1日 · The total value of biotech M&A in 2023 stood at $122.2 billion, up 45% from $84.2 billion a year earlier. The total value of pharma M&A jumped 38% year over year, from $98.5 billion in 2022 to ...
Top 25 Biotech Companies of 2023 - genengnews.com
2023年5月5日 · The biggest one-year decliner (down 40.2%) was Direxion Daily S&P Biotech Bull 3X Shares (LABU), the fifth-largest ETF with about $1.064 billion in total assets (dropping from $9.14 to $5.47). Yet ...